Annual report: the following quote in relation to Nanabis pain trial. Surely you cannot make comments in an annual report that are cannot be substantiated. This is the second time they have reported positive commentary on trial. The most likely outcome is maybe that in some cases it has had an impact of patient care - and that would presumably be consistent with empirical evidence - not sure if that would be enough to see a drug registration BUT Any chance of taking even the slightest share of global opioid market and we have a very significant valuation story.
I am long and wrong like the rest of us on this site no doubt but there is more than "hope" to this story IMO
I think trial results are due Oct or there abouts
"While this is progressing, medical doctors can apply to the Health department for supply to patients in need. We are pleased to report from feedback we have been receiving that doctors are using this process and patient outcomes are very positive."
Add to My Watchlist
What is My Watchlist?